BioCentury | Aug 15, 2019
Distillery Techniques

Mayo Clinic liquid biopsy for breast cancer residual disease

...for breast cancer residual disease LICENSING STATUS: Patent application filed; licensing status unavailable PUBLICATION DETAILS: McDonald...
BioCentury | Jan 25, 2019
Financial News

Attune raises $23M, reports safety data for angioedema candidate

...the series B funds will enable it to advance ATN-249 through Phase II testing. Andrew McDonald...
BioCentury | Jan 25, 2019
Finance

Venrock spreads HAE bets

...in the U.S. and E.U. as a prophylactic. According to Attune's co-founder and CEO Andrew McDonald...
...volunteers. The company plans to start and complete a Phase II trial in 2019, said McDonald...
BioCentury | Jan 23, 2019
Financial News

Attune raises $23M, reports safety data for angioedema candidate

...the series B funds will enable it to advance ATN-249 through Phase II testing. Andrew McDonald...
BioCentury | Dec 14, 2018
Tools & Techniques

Bigger sandbox for in silico tox

...amines. The non-profit is not a member of the in silico toxicology protocols consortium. Scott McDonald...
BioCentury | Sep 20, 2018
Company News

Management tracks: Garland to lead Portola; Gallagher joining Abingworth

...Mass.) hired Shane Kovacs as chief business and chief financial officer. Kovacs succeeds CFO Brian McDonald...
BioCentury | Sep 14, 2018
Product R&D

Academia’s manufacturing problem

...2017, academic investigators could apply for manufacturing slots that were reserved for intramural research. Cheryl McDonald...
BioCentury | Jul 28, 2017
Preclinical News

Novartis creates public portal for cancer knockdown data

...that lets researchers access all of the DRIVE study data. Novartis senior oncology researcher Robert McDonald...
...in common between these 15 cell lines that’s different than the other 385 lines?'' said McDonald...
...CCLE cell lines, and made the data accessible so researchers could explore the interactions independently. McDonald...
BioCentury | Jul 21, 2017
Strategy

Accessing miracles

...payers do reimburse for non-hospital lodging during treatment. Additionally, she said resources like the Ronald McDonald...
...NICE), London, U.K. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Ronald McDonald...
BioCentury | Jul 7, 2017
Financial News

Diasome raises $30M series A

...were the JDRF T1D Fund, Black Beret Life Sciences and an investor group led by McDonald...
Items per page:
1 - 10 of 113
BioCentury | Aug 15, 2019
Distillery Techniques

Mayo Clinic liquid biopsy for breast cancer residual disease

...for breast cancer residual disease LICENSING STATUS: Patent application filed; licensing status unavailable PUBLICATION DETAILS: McDonald...
BioCentury | Jan 25, 2019
Financial News

Attune raises $23M, reports safety data for angioedema candidate

...the series B funds will enable it to advance ATN-249 through Phase II testing. Andrew McDonald...
BioCentury | Jan 25, 2019
Finance

Venrock spreads HAE bets

...in the U.S. and E.U. as a prophylactic. According to Attune's co-founder and CEO Andrew McDonald...
...volunteers. The company plans to start and complete a Phase II trial in 2019, said McDonald...
BioCentury | Jan 23, 2019
Financial News

Attune raises $23M, reports safety data for angioedema candidate

...the series B funds will enable it to advance ATN-249 through Phase II testing. Andrew McDonald...
BioCentury | Dec 14, 2018
Tools & Techniques

Bigger sandbox for in silico tox

...amines. The non-profit is not a member of the in silico toxicology protocols consortium. Scott McDonald...
BioCentury | Sep 20, 2018
Company News

Management tracks: Garland to lead Portola; Gallagher joining Abingworth

...Mass.) hired Shane Kovacs as chief business and chief financial officer. Kovacs succeeds CFO Brian McDonald...
BioCentury | Sep 14, 2018
Product R&D

Academia’s manufacturing problem

...2017, academic investigators could apply for manufacturing slots that were reserved for intramural research. Cheryl McDonald...
BioCentury | Jul 28, 2017
Preclinical News

Novartis creates public portal for cancer knockdown data

...that lets researchers access all of the DRIVE study data. Novartis senior oncology researcher Robert McDonald...
...in common between these 15 cell lines that’s different than the other 385 lines?'' said McDonald...
...CCLE cell lines, and made the data accessible so researchers could explore the interactions independently. McDonald...
BioCentury | Jul 21, 2017
Strategy

Accessing miracles

...payers do reimburse for non-hospital lodging during treatment. Additionally, she said resources like the Ronald McDonald...
...NICE), London, U.K. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Ronald McDonald...
BioCentury | Jul 7, 2017
Financial News

Diasome raises $30M series A

...were the JDRF T1D Fund, Black Beret Life Sciences and an investor group led by McDonald...
Items per page:
1 - 10 of 113